Interstitial granulomatous drug reaction to anakinra

Journal of the American Academy of Dermatology

Volumn 59, Issue 2 SUPPL., 2008, Pages

  Regula, Christie G ^a   Hennessy, Jeannie ^a   Clarke, Loren E ^a   Adams, David R ^a   Ioffreda, Michael D ^a   Graber, Emmy M ^b   Helm, Klaus F ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b SkinCare Physicians of Chestnut Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CASE REPORT; COLLAGEN DEGRADATION; DRUG WITHDRAWAL; ELASTIC FIBER; FEMALE; HISTIOCYTE; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; PAPULE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN GRANULOMA; SKIN MANIFESTATION; SKIN NODULE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG ERUPTIONS; FEMALE; GRANULOMA; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MIDDLE AGED;

EID: 46749109197     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.11.004     Document Type: Article

References (13)

1. Magro C.M., Crowson A.N., and Schapiro B.L. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol 25 (1998) 72-78
2. Fujita Y., Shimizu T., and Shimizu H. A case of interstitial granulomatous drug reaction due to sennoside. Br J Dermatol 150 (2004) 1035-1037
3. Lee H., Yun W., Lee M., Choi J., Moon K., and Koh J. Interstitial granulomatous drug reaction caused by Chinese herbal medication. J Am Acad Dermatol 52 (2005) 712-713
4. In: Barhill R.L. (Ed). Textbook of dermatopathology. 2nd ed. (2004), McGraw-Hill, New York 315
5. In: McKeen P.H. (Ed). Essential skin pathology (1999), Mosby, Philadelphia 55-62
6. Ackerman A.B., White W.L., Guo Y., et al. Differential diagnosis in dermatopathology vol. 4 (1994), Lea & Febiger, Philadelphia pp. 34-7
7. Chu P., Connolly M.K., and LeBoit P.E. The histiopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol 130 (1994) 1278-1283
8. Crowson A.N., Nuovo G., Ferri C., and Magro C.M. The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases. Hum Pathol 24 (2003) 573-579
9. Long D., Thiboutot D.M., Majeski J.T., Vasily D.B., and Helm K.F. Interstitial granulomatous dermatitis with arthritis. J Am Acad Dermatol 34 (1996) 957-961
10. Ferren M., Gallarado F., Salar A., Iglesias M., Barranco C., and Pufol R.M. Granulomatous Dermatits with enlarged histiocytes: a characteristic pattern of granulocyte colony-stimulating factor. Dermatology 212 (2006) 188-193
11. Callen J.P. Complications and adverse reactions in the use of newer biological agents. Semin Cutan Med Surg 26 (2007) 6-14
12. den Broder A.A., de Jang E., Franssen M.J.A.M., Jeurissen M.E.C., Flendrie M., and van den Hoogen F.H.J. Obsevational study of efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice. Ann Rheum Dis 65 (2006) 760-762
13. Deng A., Harvey V., Sina B., Strobel D., Badros A., Junkins-Hopkins J.M., et al. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Arch Dermatol 142 (2006) 198-202